Brand & Generic Names
KPAB |
|
Potaba |
|
Potassium Aminobenzoate |
|
Potassium Para-aminobenzoate |
|
Basic Information
- Habit forming? No
- Prescription needed? Yes
- Available as generic? No
- Drug class: Antifibrosis
Uses
Reduces inflammation and relieves contractions in tissues lying
under the skin that have become tight from such disorders as
dermatomyositis, Peyronie's disease, scleroderma, pemphigus,
morphea.
Dosage & Usage Information
How to take:
Tablets--Dissolve in liquid or take with food to prevent
stomach upset.
Capsules--Take with full glass of liquid.
Oral solution--Swallow with liquid to lessen stomach upset.
Powder--Mix with liquid.
When to take:
At the same times each day, according to instructions on
prescription label. Usually taken with meals and at bedtime with
a snack.
If you forget a dose:
Take as soon as you remember up to 2 hours
late. If more than 2 hours, wait for next scheduled dose (don't
double this dose).
What drug does:
May increase ability of diseased tissues to use oxygen.
Time lapse before drug works:
May require 3 to 10 months for
improvement to begin.
Don't take with:
Any other medicine without consulting your doctor or pharmacist.
Overdose
SYMPTOMS:
Nausea, vomiting.
WHAT TO DO:
Overdose unlikely to threaten life. If person takes much larger
amount than prescribed, call doctor, poison-control center or
hospital emergency room for instructions.
Possible Adverse Reactions or Side Effects
Life-threatening:
Common:
Appetite loss, nausea,
rash, fever.
Infrequent:
- Low blood sugar
(hunger, anxiety,
cold sweats,
rapid pulse).
- Sore throat.
Rare:
Warnings & Precautions
Don't take if:
You are allergic to aminobenzoate potassium or aminobenzoic acid
(PABA).
Before you start, consult your doctor:
- If you have low blood sugar.
- If you have diabetes mellitus.
- If you have kidney disease.
Over age 60:
Adverse reactions and side effects may be more frequent and
severe than in younger persons, particularly low blood sugar.
Pregnancy:
Safety not established. Consult doctor.
Breast-feeding:
Unknown effect. Consult doctor.
Infants & children:
Not recommended. Safety and dosage have not been established.
Prolonged use:
Talk to your doctor about the need for follow-up medical
examinations or laboratory studies to check complete blood
counts (white blood cell count, platelet count, red blood cell
count, hemoglobin, hematocrit).
Skin & sunlight:
No problems expected.
Driving, piloting or hazardous work:
No problems expected.
Discontinuing:
No problems expected.
Others:
If you become acutely ill and cannot eat well for even a short
while, tell your doctor. These circumstances can lead to low
blood sugar, and dosage may need adjustment.
Possible Interaction with Other Drugs
GENERIC NAME |
COMBINED EFFECT |
| |
------------------------ |
----------------------- |
Dapsone |
Decreased dapsone effect. |
Methotrexate |
Increased methotrexate effect and |
|
toxicity. |
Salicylates* |
May increase salicylate blood |
|
level. |
Sulfa drugs* |
Decreased sulfa effect. |
| |
Possible Interaction with Other Substances
INTERACTS WITH |
COMBINED EFFECT |
--------------- |
--------------- |
Alcohol: |
None expected. |
| |
Beverages: |
None expected. |
| |
Cocaine: |
None expected. |
| |
Foods: |
None expected. |
| |
Marijuana: |
None expected. |
| |
Tobacco: |
None expected. |
|